Skip to NavigationSkip to content

Keytruda/chemo combo recommended for first-line lung cancer via Cancer Drugs Fund

Published on 08/08/19 at 09:37am

MSD’s Keytruda (pembrolizumab) has secured recommendation from NICE for inclusion on the Cancer Drugs Fund (CDF) in combination with chemotherapy in the first-line treatment of untreated metastatic squamous non-small cell lung cancer (NSCLC), it has emerged.

The final appraisal determination marks the first for a immunotherapy/chemotherapy combo in this indication regardless of PD-L1 expression. The ruling stipulates that the combo should only be used in patients who have stopped at two years of uninterrupted treatment with Keytruda, or earlier in the event of disease progression.

The decision was reached based on Phase 3 data which showed that the combo imrpved overall survival by 15.9 months compared to 11.3 months and reduced the risk of death by 36% when compared to chemotherapy alone. Additionally, the combo extended progression free survival by 44%, while the objective response rate was 57.9% compared to chemo alone.

“It is of great and lasting importance that we will now be able to offer patients with advanced squamous non-small cell lung cancer (NSCLC), the combination of chemotherapy plus pembrolizumab as a first line treatment option,” remarked Professor Gary Middleton, Professor of Medical Oncology at the University of Birmingham. “Progress in the first line treatment of this cancer has been frustratingly slow and, until this time, there has not been any agent which, when added to chemotherapy, provides really robust and clinically meaningful benefits over chemotherapy alone. The addition of pembrolizumab significantly improves overall survival compared to chemotherapy alone and, importantly, across all strata of tumour cell PD-L1 expression. The combination of pembrolizumab and chemotherapy in eligible patients with advanced squamous NSCLC should now become the first line standard of care and the benchmark for future first line studies in this disease.”

Louise Houson, UK Managing Director at MSD, said: “We are pleased that following this approval the majority of lung cancer patients now have access to some form of immunotherapy, including those patients with particularly hard to treat forms of this disease. We have, as ever, worked collaboratively with NHS England and NICE to ensure the value of pembrolizumab in combination with chemotherapy is recognised. Enabling access to the first immunotherapy/chemotherapy combination for this form of lung cancer in the first line setting will make a real difference to patients. We hope that this continues as we look to bring more indications to market in the near future.”

Matt Fellows

Comments

This article was written by a real thinking writer. I agree many of the with the solid points made by the writer. I’ll be back. เว็บแทงบอลเต็ง

Nice post mate, keep up the great work, just shared this with my friendz บอลสเต็ป

I found this is an informative and interesting post so i think so it is very useful and knowledgeable. I would like to thank you for the efforts you have made in writing this article. ทางเข้า UFABET

Nice post mate, keep up the great work, just shared this with my friendz เว็บผลบบอล

Fantastic blog you have here. You’ll discover me looking at your stuff often. Saved! Kingsmaker

I learn some new stuff from it too, thanks for sharing your information. slotenmaker voorburg

I learn some new stuff from it too, thanks for sharing your information. undefined

I learn some new stuff from it too, thanks for sharing your information. how many hearts does an octopus have

Thanks for the blog post buddy! Keep them coming... dashburst

Great post, and great website. Thanks for the information! دكتور جراحة قلب

I learn some new stuff from it too, thanks for sharing your information. wedding photo list

I can set up my new idea from this post. It gives in depth information. Thanks for this valuable information for all,.. exotic car rentals in Miami

i am for the first time here. I found this board and I in finding It truly helpful & it helped me out a lot. I hope to present something back and help others such as you helped me. Car Show Displays

i am for the first time here. I found this board and I in finding It truly helpful & it helped me out a lot. I hope to present something back and help others such as you helped me. car show boards

Information on various Korean casino sites and baccarat sites Converter

I have bookmarked your blog, the articles are way better than other similar blogs.. thanks for a great blog! gcp certification

This is just the information I am finding everywhere. Thanks for your blog, I just subscribe your blog. This is a nice blog.. Pablo Ignacio González Carbonell Royal Holiday

This is just the information I am finding everywhere. Thanks for your blog, I just subscribe your blog. This is a nice blog.. Pablo Ignacio González Carbonell Royal Holiday

useful information on topics that plenty are interested on for this wonderful post.Admiring the time and effort you put into your b!.. Camp Southern Group

I am very enjoyed for this blog. Its an informative topic. It help me very much to solve some problems. Its opportunity are so fantastic and working style so speedy. HillCo Partners economic update

I am very much pleased with the contents you have mentioned. I wanted to thank you for this great article. HillCo Partners Legislative process

It was a very good post indeed. I thoroughly enjoyed reading it in my lunch time. Will surely come and visit this blog more often. Thanks for sharing. kim anami goop

Thanks for providing recent updates regarding the concern, I look forward to read more. Isidoro Quiroga Chile

Your article has piqued a lot of positive interest. I can see why since you have done such a good job of making it interesting. sell my house fast

Thank you for some other informative website. The place else may just I get that kind of information written in such a perfect method? I have a venture that I am simply now running on, and I’ve been at the glance out for such info. Crawfish

Thanks a lot for sharing us about this update. Hope you will not get tired on making posts as informative as this. backlit booth displays

Thanks for taking the time to discuss this, I feel strongly about it and love learning more on this topic. If possible, as you gain expertise, would you mind updating your blog with more information? It is extremely helpful for me. Atlassia Price

Excellent .. Amazing .. I’ll bookmark your blog and take the feeds also…I’m happy to find so many useful info here in the post, we need work out more techniques in this regard, thanks for sharing. 꽁머니 3만

Excellent .. Amazing .. I’ll bookmark your blog and take the feeds also…I’m happy to find so many useful info here in the post, we need work out more techniques in this regard, thanks for sharing. 꽁머니 3만

Excellent .. Amazing .. I’ll bookmark your blog and take the feeds also…I’m happy to find so many useful info here in the post, we need work out more techniques in this regard, thanks for sharing. usa priority security in Sunrise, FL

Excellent .. Amazing .. I’ll bookmark your blog and take the feeds also…I’m happy to find so many useful info here in the post, we need work out more techniques in this regard, thanks for sharing. Vending Services Dallas

I wish more authors of this type of content would take the time you did to research and write so well. I am very impressed with your vision and insight. General Contractors in Tyler

Thanks for taking the time to discuss this, I feel strongly about it and love learning more on this topic. Buy Oxycontin Pills Online

Thanks, that was a really cool read! hasil jepang togel

This is a brilliant blog! I'm very happy with the comments!.. air conditioning climate control

This is such a great resource that you are providing and you give it away for free. chat sites

Thanks you very much for sharing these links. Will definitely check this out.. bespoke jacket

It is imperative that we read blog post very carefully. I am already done it and find that this post is really amazing. omz-software

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches